| Revenue growth | Value |
|---|---|
| 3Y CAGR | 0% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +50% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,893.20 -85.00 (1.71%) | 22,759.95 | 30.96 | 5.42 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,504.00 -56.80 (2.22%) | 19,444.55 | 28.68 | 5.42 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,238.50 -177.00 (2.39%) | 18,526.25 | 109.22 | 21.23 | ||
Natco PharmaNATCOPHARM | ₹885.00 +2.60 (0.29%) | 15,806.45 | 13.81 | 1.71 |